Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
101,962
Value
$3.45M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026101,962$3.45M<0.1%+688+0.7%AddedHolders
Q1 2026101,274$3.05M<0.1%−3,646−3.5%ReducedHolders
Q4 2025104,920$3.27M<0.1%+13,844+15.2%AddedHolders
Q3 202591,076$1.84M<0.1%+1,918+2.2%AddedHolders
Q2 202589,158$1.49M<0.1%−5,428−5.7%ReducedHolders
Q1 202594,586$1.45M<0.1%+5,667+6.4%AddedHolders
Q4 202488,919$1.96M<0.1%+2,408+2.8%AddedHolders
Q3 202486,511$1.56M<0.1%+5,257+6.5%AddedHolders
Q2 202481,254$1.32M<0.1%+10,631+15.1%AddedHolders
Q1 202470,623$996.5K<0.1%+49,054+227.4%AddedHolders
Q4 202321,569$225.2K<0.1%−395−1.8%ReducedHolders
Q3 202321,964$224.0K<0.1%00.0%UnchangedHolders
Q2 202321,964$165.4K<0.1%00.0%UnchangedHolders
Q1 202321,964$194.4K<0.1%−500−2.2%ReducedHolders
Q4 202222,464$204.9K<0.1%−400−1.7%ReducedHolders
Q3 202222,864$185.0K<0.1%+2,559+12.6%AddedHolders
Q2 202220,305$153.0K<0.1%−1,495−6.9%ReducedHolders
Q1 202221,800$205.0K<0.1%+187+0.9%AddedHolders
Q4 202121,613$173.0K<0.1%−2,109−8.9%ReducedHolders
Q3 202123,722$231.0K<0.1%−1,600−6.3%ReducedHolders
Q2 202125,322$251.0K<0.1%−1,396−5.2%ReducedHolders
Q1 202126,718$308.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.